Data / Drug companies / Desogestrel and ethinyl estradiol
Desogestrel and ethinyl estradiol: 12 companies and 16 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Desogestrel and ethinyl estradiol is listed in the FDA National Drug Code Directory by 12 companies, with 16 products in commercial distribution. 16 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are kit, and the newest product started marketing on March 18, 2026.
The request: Get every company that lists desogestrel and ethinyl estradiol in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 12
- Products
- 16
- Generic (ANDA) products
- 16 (100.0%)
- Application numbers
- 9
- Brand names
- Volnea, Apri 28 Day, Isibloom, Cyred Eq, Velivet Triphasic Regimen, Reclipsen 28 Day, Enskyce, Juleber
- openFDA record search
- api.fda.gov
Companies that list desogestrel and ethinyl estradiol
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 3 | kit | Generic drugs (ANDA) | February 1, 2018 |
| Teva Pharmaceuticals USA, Inc. | 2 | kit | Generic drugs (ANDA) | March 1, 2004 |
| Xiromed, LLC | 2 | kit | Generic drugs (ANDA) | February 1, 2018 |
| A-S Medication Solutions | 1 | kit | Generic drugs (ANDA) | October 22, 1999 |
| Afaxys Pharma, LLC | 1 | kit | Generic drugs (ANDA) | May 17, 2017 |
| Aurobindo Pharma Limited | 1 | kit | Generic drugs (ANDA) | May 17, 2017 |
| Camber Pharmaceuticals, Inc. | 1 | kit | Generic drugs (ANDA) | March 18, 2026 |
| Lupin Pharmaceuticals, Inc. | 1 | kit | Generic drugs (ANDA) | December 10, 2024 |
| Mayne Pharma Inc. | 1 | kit | Generic drugs (ANDA) | October 4, 2020 |
| Naari Pte Limited | 1 | kit | Generic drugs (ANDA) | March 31, 2024 |
| NorthStar Rx LLC | 1 | kit | Generic drugs (ANDA) | July 12, 2013 |
| Teva Pharmaceuticals USA, Inc. | 1 | kit | Generic drugs (ANDA) | January 1, 2017 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Kit | 16 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 16 | 100% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.